PBAC ‘has now seen sense’ on fluticasone

Megan Haggan 16/05/2023

The controversial decision to restrict prescribing fluticasone propionate for young children has been reversed in a move welcomed by the Guild But families and pharmacists have been left without clear answers as to when they will be able to access the medicine via the Pharmaceutical Benefits Scheme, says one key stakeholder. As reported last month,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

PBAC ‘has now seen sense’ on fluticasone

Previous ‘We needed this like a hole in the head’

Next Provisional rego numbers hit record high

MENU

ajp.com.au

Previous ‘We needed this like a hole in the head’

Next Provisional rego numbers hit record high

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.